ARCHIVES

FDA Didn’t Tell Advisors About Data Linking Obesity Drug With Precancerous Lesions.

This article is from The Cancer Letter archive.

Vol. 32 No. 21 | June 2, 2006

Download PDF Visit The Full Archive

Related Articles

Drug Shortage A Boon For Levoleucovorin; Price Is 60 Times Higher Than Leucovorin

January 16, 2009

First Report On Carcinogens Now Avaiable

October 3, 1980

In this 16-page issue: The Wall Street Journal editorial page leads campaign against efficacy standard.

August 5, 2005

Advice Rolls In As Upton Proceeds With NCI Reorganization, Stands Firm On His Program

March 17, 1978

Supporters And A Critic Of Burzynski Comment

October 30, 1998

Cediranib Demonstates Control In Alveolar Soft Part Sarcoma

May 31, 2013